EUVIMEDEUVIMED entdecken
Open Access

Gene Therapy Targeting GD3 Synthase Protects Against MPTP‐Induced Parkinsonism and Executive Dysfunction

Panchanan Maiti, Yi Xue, Tonia S Rex, Michael P McDonald iD

European Journal of Neuroscience · 2025-03 · 61 (6)

DOI: 10.1111/ejn.70061 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Neuroscience, online erschienen am 16.03.2025. Verfasst von Panchanan Maiti und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University of Tennessee Health Science Center, Memphis, Tennessee, USA. Hauptthemen laut MEDLINE: Genetic Therapy, Sialyltransferases, Parkinsonian Disorders, Executive Function. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NINDS NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

More than half of Parkinson's patients exhibit fronto‐striatally mediated executive dysfunction, including deficits in sustained attention, judgment, and impulse control. We have previously shown that modification of brain gangliosides by targeted deletion of GD3 synthase (GD3S) is neuroprotective in vivo and in vitro. The objective of the present study was to determine whether GD3S knockdown will protect neurons and prevent executive dysfunction following a subchronic regimen of 25‐mg/kg 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP). C57BL/6N wild‐type mice were assessed on a battery of sensorimotor tasks and a reaction‐time task that included measures of sustained attention and impulse control. Sustained attention was measured by response accuracy and reaction time; impulsivity was measured by premature responding in the response holes or the food well during the precue period. After reaching stable performance, mice received intrastriatal injections of a recombinant adeno‐associated viral (AAV) vector expressing a short‐hairpin RNA (shRNA) construct targeting St8sia1 , the gene that codes for GD3S, or a scrambled‐sequence control (scrRNA). After 4 weeks, mice received MPTP or saline injections. MPTP‐lesioned mice in the scrRNA control group exhibited loss of impulse control in the sessions following MPTP injections, compared to the other three groups. These deficits abated with extended training but re‐emerged on challenge sessions with shorter cue durations or longer precue durations. GD3S knockdown partially protected nigrostriatal neurons from MPTP neurotoxicity and prevented the motor impairments (coordination, bradykinesia, fine motor skills) and loss of impulse control. Our data suggest that inhibition of GD3S warrants further investigation as a novel therapeutic strategy for Parkinson's disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genetic TherapySialyltransferasesParkinsonian DisordersExecutive FunctionMPTP PoisoningAnimalsMice, Inbred C57BLMiceMaleRNA, Small Interfering

Stichwörter der Autor:innen

Parkinson's diseaseexecutive functiongangliosidesgene therapyneurodegenerationsustained attention

Substanzen

alpha-N-acetylneuraminate alpha-2,8-sialyltransferaseSialyltransferasesRNA, Small Interfering

Autor:innen und Institutionen

  • Department of Neurology, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
  • Department of Ophthalmology, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
  • Department of Ophthalmology and Visual Sciences, Vanderbilt University, Nashville, Tennessee, USA.
  • Department of Anatomy & Neurobiology, Neuroscience Institute, University of Tennessee Health Science Center, Memphis, Tennessee, USA.

ORCID-Profile: Michael P McDonald

Förderung

  • NIA NIH HHS
  • NINDS NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Maiti, P., Xue, Y., Rex, T. S., & McDonald, M. P. (2025). Gene Therapy Targeting GD3 Synthase Protects Against MPTP‐Induced Parkinsonism and Executive Dysfunction. European Journal of Neuroscience, 61(6). https://doi.org/10.1111/ejn.70061

Vancouver

Maiti P, Xue Y, Rex TS, McDonald MP. Gene Therapy Targeting GD3 Synthase Protects Against MPTP‐Induced Parkinsonism and Executive Dysfunction. European Journal of Neuroscience. 2025;61(6). doi:10.1111/ejn.70061

BibTeX
@article{Maiti2025,
  author = {Maiti, Panchanan and Xue, Yi and Rex, Tonia S and McDonald, Michael P},
  title = {Gene Therapy Targeting GD3 Synthase Protects Against MPTP‐Induced Parkinsonism and Executive Dysfunction},
  journal = {European Journal of Neuroscience},
  year = {2025},
  volume = {61},
  number = {6},
  doi = {10.1111/ejn.70061}
}
Kostenlos starten →